Acadian Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.91M | Buy |
+1,350,185
| New | +$4.91M | 0.01% | 589 |
|
|
2024
Q3 | – | Sell |
-4,063,383
| Closed | -$4.14M | – | 2062 |
|
|
2024
Q2 | $4.14M | Sell |
4,063,383
-1,246,372
| -23% | -$1.27M | 0.01% | 547 |
|
|
2024
Q1 | $9.72M | Sell |
5,309,755
-1,605,748
| -23% | -$2.94M | 0.03% | 309 |
|
|
2023
Q4 | $8.57M | Sell |
6,915,503
-307,985
| -4% | -$382K | 0.03% | 326 |
|
|
2023
Q3 | $8.23M | Sell |
7,223,488
-236,865
| -3% | -$270K | 0.03% | 323 |
|
|
2023
Q2 | $6.82M | Sell |
7,460,353
-22,700
| -0.3% | -$20.8K | 0.03% | 375 |
|
|
2023
Q1 | $4.19M | Hold |
7,483,053
| – | – | 0.02% | 505 |
|
|
2022
Q4 | $4.32M | Hold |
7,483,053
| – | – | 0.02% | 483 |
|
|
2022
Q3 | $2.37M | Buy |
7,483,053
+144,010
| +2% | +$45.5K | 0.01% | 586 |
|
|
2022
Q2 | $2.59M | Buy |
+7,339,043
| New | +$2.59M | 0.01% | 568 |
|
|
2021
Q3 | – | Sell |
-10,636
| Closed | -$40K | – | 1698 |
|
|
2021
Q2 | $40K | Buy |
10,636
+8,536
| +406% | +$32.1K | ﹤0.01% | 1831 |
|
|
2021
Q1 | $7K | Sell |
2,100
-833,985
| -100% | -$2.78M | ﹤0.01% | 2016 |
|
|
2020
Q4 | $2.34M | Buy |
836,085
+116,768
| +16% | +$327K | 0.01% | 717 |
|
|
2020
Q3 | $1.81M | Buy |
719,317
+715,611
| +19,310% | +$1.8M | 0.01% | 698 |
|
|
2020
Q2 | $50K | Buy |
+3,706
| New | +$50K | ﹤0.01% | 1917 |
|
|
2018
Q4 | – | Sell |
-73,516
| Closed | -$649K | – | 1710 |
|
|
2018
Q3 | $649K | Sell |
73,516
-27,158
| -27% | -$240K | ﹤0.01% | 829 |
|
|
2018
Q2 | $1.01M | Sell |
100,674
-199,758
| -66% | -$1.99M | ﹤0.01% | 727 |
|
|
2018
Q1 | $2.86M | Sell |
300,432
-324,735
| -52% | -$3.09M | 0.01% | 519 |
|
|
2017
Q4 | $9.3M | Sell |
625,167
-103,062
| -14% | -$1.53M | 0.04% | 289 |
|
|
2017
Q3 | $14.3M | Buy |
728,229
+357,491
| +96% | +$7.03M | 0.06% | 237 |
|
|
2017
Q2 | $5.33M | Buy |
370,738
+74,179
| +25% | +$1.07M | 0.02% | 383 |
|
|
2017
Q1 | $2.73M | Buy |
+296,559
| New | +$2.73M | 0.01% | 543 |
|